Superworth

Biohaven price to book ratio BHVN

Market value divided by the book value of the company's net assets, since 2022.

Today, Nov 2, 2026
n/m
not a meaningful number
Last meaningful
172×
Oct 2026
4-year median
10.6×
4-year range
1.6× to 194×
Peer median
3.0×

Biohaven's price to book ratio is not a meaningful number today: shareholders' equity was zero, negative or not reported, so price to book does not exist.

It was last meaningful in Oct 2026, at 172×.

On the days it had one over the last 4 years, its median was 10.6×, from 1.6× in Apr 2023 to 194× in Sep 2026.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far172×10.2×194×
20256.5×4.2×13.5×
202411.7×7.4×14.7×
202311.8×1.6×12.8×
20229.4×9.3×11.4×

Against its peers

Companies in Drug Manufacturers - General nearest Biohaven's size, closest first, today.

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Biohaven

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.